increased appetite on semaglutide for Weight Loss FAQ's Weight Loss Drug Semaglutide ( GLP-1 ) in

Patients experience significant fat loss, often faster and more efficiently than with other medications

A possible dose-dependent relationship between GLP-1R agonists and changes in hemodynamic parameters exists, that includes, lowering 24-h SBP (3 mmHg), increasing HR (24 bpm)

In the retina, GLP-1R agonists have specifically protected retinal ganglion and glia cells, such as the Mller glia, from various stresses (Hao et al., 2012

Large clinical trials demonstrate an acceptable safety profile when used as directed under medical supervision

More than three-quarters of patients taking both drugs reported at least one side effect, mostly mild to moderate gastrointestinal issues such as nausea, constipation, diarrhea and vomiting